Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.845
-0.055 (-6.15%)
At close: Mar 9, 2026, 4:00 PM EDT
0.900
+0.055 (6.53%)
After-hours: Mar 9, 2026, 7:35 PM EDT
Aprea Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 18 | 18 | 18 | - | - |
| Market Cap Growth | -61.72% | 1.81% | 0.11% | - | - | - |
| Enterprise Value | -8 | -7 | -6 | -12 | - | - |
| Last Close Price | 0.84 | 3.29 | 4.70 | 6.62 | - | - |
| PS Ratio | 12.10 | 11.90 | 30.11 | - | - | - |
| PB Ratio | 0.46 | 0.87 | 0.96 | 0.65 | - | - |
| P/TBV Ratio | 0.54 | 0.93 | 1.04 | 0.68 | - | - |
| Debt / Equity Ratio | - | - | - | - | 0.00 | - |
| Net Debt / Equity Ratio | -1.18 | -1.11 | -1.18 | -1.07 | -1.07 | - |
| Net Debt / EBITDA Ratio | 0.99 | 1.60 | 1.40 | 0.77 | 1.41 | - |
| Net Debt / FCF Ratio | 1.02 | 1.68 | 1.76 | 1.15 | 1.40 | - |
| Asset Turnover | 0.02 | 0.06 | 0.02 | - | - | - |
| Quick Ratio | 5.12 | 6.80 | 4.93 | 8.99 | 7.25 | - |
| Current Ratio | 5.20 | 7.02 | 5.14 | 9.42 | 7.73 | - |
| Return on Equity (ROE) | -74.72% | -66.66% | -63.19% | -294.69% | - | - |
| Return on Assets (ROA) | -41.90% | -38.39% | -36.62% | -53.71% | - | - |
| Return on Capital Employed (ROCE) | -118.70% | -69.50% | -84.70% | -138.60% | -75.60% | - |
| Earnings Yield | -220.68% | -72.47% | -81.35% | -642.23% | - | - |
| FCF Yield | -227.54% | -75.90% | -69.87% | -142.58% | - | - |
| Buyback Yield / Dilution | -23.17% | -52.31% | -118.31% | -55.69% | -0.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.